NIKA PHARMACEUTICALS, INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nika Pharmaceuticals, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Nika Pharmaceuticals, Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 1.02B shares, a 16.3% increase year-over-year.
  • Nika Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 876M shares, a 21% increase from 2022.
  • Nika Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 724M shares, a 82.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 1.02B +142M +16.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 876M 0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-28
Q4 2023 876M +152M +21% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 876M +135M +18.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 876M +135M +18.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 876M +480M +121% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-28
Q4 2022 724M +328M +82.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 741M +345M +87% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 741M +345M +87% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 396M +383M +2900% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 396M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-10
Q3 2021 396M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 396M Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-07
Q1 2021 13.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.